In addition to the advancements in medical imaging technology for human healthcare, there have also been significant developments in veterinary imaging technology. MiREYE Imaging, a company based in the United States, has recently launched a line of AI-based Veterinary X-ray machines. These machines incorporate a patented Auto Thickness Detection system, which eliminates the need for manual adjustments and ensures precise and optimal imaging results. By integrating artificial intelligence into veterinary imaging, MiREYE Imaging aims to revolutionize diagnostic imaging in veterinary care and provide advanced imaging solutions for veterinary practices nationwide [c2d202b8].
The AI-based Veterinary X-ray machines developed by MiREYE Imaging offer several benefits for veterinary practices. The incorporation of artificial intelligence allows for more accurate and efficient imaging, reducing the need for manual adjustments and minimizing the risk of errors. The Auto Thickness Detection system ensures that the imaging results are precise and optimal, improving the diagnostic capabilities of veterinarians. MiREYE Imaging is actively expanding its network of distribution partners to make these AI-based Veterinary X-ray machines accessible to veterinary practices across the United States, further advancing veterinary care and diagnostics [c2d202b8].
AEYE Health and Optomed have collaborated to launch Aurora AEYE, the first portable, fully autonomous screening solution for diabetic retinopathy. This AI-powered solution is the first of its kind to receive FDA clearance. It requires just one image per eye and provides instant results directly on the camera screen for patients, along with diagnostic reports for healthcare providers. Aurora AEYE streamlines insurance reporting and care gap closure with automatically generated diagnostic reports. Diabetic retinopathy affects approximately 40 million people in the U.S. and over 500 million worldwide. The launch of Aurora AEYE aims to enhance accessibility and efficiency in screening, ultimately improving patient outcomes and promoting global health equity [e70ae1eb].